Characterization of delivery systems for nanomedicine Dr. John A. Dagata.

Slides:

Advertisements

Similar presentations

List of the “bullet points” in the first FP7 calls for proposals

Advertisements

Mechanical and Industrial Engineering University of Massachusetts Amherst, MA, USA Nanomedicine Jonathan P. Rothstein.

Mechanical and Industrial Engineering University of Massachusetts Amherst, MA, USA Nanomedicine Jonathan P. Rothstein.

Mechanical and Industrial Engineering University of Massachusetts Amherst, MA, USA Nanomedicine Jonathan P. Rothstein.

Parallel Session 9 Contemporary Challenges in Statistical Evaluation of Diagnostic Products Chairs:Gene Pennello (CDRH) Lakshmi Vishnuvajjala (CDRH) Stuart.

Nanotechnology and cancer Maria Guirguis Dr. Sun Biomedical Engineering Seminar 1.

ACRIN Fall Meeting 2009 ACRIN Adverse Event Reporting Manual Revisions Presented by: Cornelia Tsikos, BS, MS.

List of the “bullet points” in the first FP7 calls for proposals of direct relevance to nanotechnology Disclaimer: Note that this compilation is not legally.

Nanoscale Imaging Probes for Personalized Medicine Undergraduate Researchers Leslie Chan, Rahul Balusu and Alice Chan Mentors Efstathios Karathanasis,

NCI Designation: Expanding Science and Promoting Health in the Region Name Title, Company Date.

PULSE IMAGING, Inc. Company Overview 11/12/08 A World Without Skin Biopsies NON-INVASIVE EARLY SKIN CANCER DIAGNOSTIC SYSTEM.

Research Protocol ACRIN 6678 Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?

Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.

Consent for Research Study A Study for Women with Advanced Cervical Cancer: Learning whether an MRI scan with an investigative contrast agent (called.

FDA’s Critical Path to New Medical Product Development Opportunities from the Center for Devices and Radiological Health Larry Kessler, Sc.D., Director.

©Immunotrex Biologics 2014 CONFIDENTIAL 1 PEG Nanoparticles: Production and Drug Delivery Structure and Function Principles of the NanoKit: A Laboratory.

Nanotechnology in Drug Discovery- Development and Delivery

Challenges in Clinical Applications for Nanotechnology N. Tony Eissa, MD Table 3.

Nanotechnology in Drug Delivery for Cancer Current Technologies

Cancer Nanotechnology: New Opportunities for Targeted Therapies FDA Public Meeting October 10, 2006 Piotr Grodzinski, Ph.D. Director, Nanotechnology for.

Near-Field Optical Microscope with an Integrated Nanometer-Sized Light Emitting Diode John X.J. Zhang (P.I.) & Kazunori Hoshino Department of Biomedical.

ACPS October Nanotechnology: Issues and Future Directions Nakissa Sadrieh Ph.D. OPS/CDER/FDA.

N ANOPARTICLES IN BIOLOGY AND MEDICINE Antti Rautiainen KE Nanopartikkelit.

Nanoparticles and their medical applications

ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.

NIH/NASA Meeting on Space-Related Health Research Henry Rodriguez, Ph.D., M.B.A. Director, Clinical Proteomic Technologies Initiative National Cancer Institute.

Defining the right clinical problems for nanotechnology Table 2 John S. Oghalai, MD.

Partnering with Federal Labs: A Panel Discussion FLC Mid-Atlantic Region Annual Meeting October 24, 2007.

Grand Challenges for Nanomedicine and Nanobiology Workshop Houston, Texas August 27 th, 2007.

REGULATORY CHALLENGES FOR NANOMATERIALS IN PUBLIC HEALTH Driving Faster Than Our Nano-Headlights AAAS Annual Meeting February 13, 2009 Norris E. Alderson,

Applications of Nanotechnology. Since the 1980's electronics has been a leading commercial driver for nanotechnology R&D, but other areas (materials,

Development of Alternative and Durable High Performance Cathode Supports for PEM Fuel Cells Cost-Effective Corrosion Protection to Lengthen Fuel Cell Life.

Centrifugal Length Sorting of Carbon Nanotubes Dr. Jeffrey Fagan.

Nanoscience and Health Research. The role of nanotechnology in: Fighting disease causing organisms. Developing medical devices. Faster diagnoses.

Update From FDA: Office of the Commissioner and Center for Drug Evaluation and Research Janet Woodcock, M.D. Acting Deputy Commissioner for Operations.

Biomedical Applications of Scanning Probe Microscopy

Nanotechnology in Cancer Treatment

Title: Anisotropic Colloidal Magnetic Nanostructures NSF Award Numbers: # Recent years have witnessed a remarkable convergence of physical sciences,

The SNM Centralized IND & Clinical Trials Network Enabling Implementation Investigational & Approved PET Imaging in Multicenter Clinical Trials George.

Nanotechnology will change the nature of almost every human-made object in the next century.

Consent for Research Study A study using 18 F-Fluoride for prostate cancer patients currently enrolled in Dr. Febbo’s “Genomic Guided Therapy” study A.

Nanomechanics Track Summary NNI Instrumentation and Metrology Grand Challenge Workshop January 29, 2004.

Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.

THE UNIVERSITY OF AT AUSTIN Department of Chemical Engineering Institute for Computational Engineering & Sciences Texas Materials Institute Institute for.

Nanotechnology The concept of nanotechnology is defined as an art handling of tiny particles (1nm= m). The structures have different properties.

2005 Federal Laboratory Consortium Mid-Atlantic Regional Meeting September 14, 2005 Terry Lynch Office of Technology Partnerships.

Dinutuximab (ch14.18) for children with high-risk neuroblastoma

Nanoparticles for Medical and Surgical Tumor Therapy Departments of Radiology, Oncology and Biomedical Engineering Emory University School of Medicine.

High-voltage nanoimprint lithography of refractory metal films Dr. John A. Dagata.

Laurie E. Locascio, Ph.D. Director, MML/NIST NIST/MML: Measurement Assurance for Biological Systems.

Molecular Biomarkers & Targets an overview Michael Messenger NIHR Diagnostic Evidence Co-Operative & Leeds Cancer Research UK Centre.

Targeted inorganic nanodevices for breast cancer diagnosis and therapy Fiandra Luisa Nanomedicine Laboratory Luigi Sacco University Hospital Milan Italy.

The critical role of carbohydrate post translational modifications on cell surface proteins and those bound to circulatory proteins is well recognized.

Group 37 – Chris Peng (Presenter), Arvin Soepriatna, Blessan Sebastian Client: Mr. Mike Sabo, Pulse Therapeutics, Inc. BME 401, Prof. Anastasio 10/2/2013.

Single Cell Analysis Systems for Therapeutic Discovery

Clinical Research Contribution towards improving Clinical Care

Business Development Manager

Novel Polyglutamate-based Indocyanine green nanoparticles for photothermal cancer therapy Sam P. Tarassoli.

Project Promoter: University of Tartu

National and International Efforts worth knowing about

BTY100-Lec 2.3 Nanobiotechnology.

Since the 1970s, the innovative development of nanoparticles is due to a combination of theory and experiments in the fields of physics chemistry materials.

Learning About PET/CT Scans:

Non-PEGylated Liposome Production Non-PEGylated Liposome Production —Creative Biostructure.

From Bench to Clinical Applications: Money Talks

PAST, PRESENT AND FUTURE

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

The NIDA Standardized Research E-Cigarette (SREC)

MD Tech Council – Doing Biz w/ NIH

Nanotechnology: Issues and Future Directions

Presentation transcript:

Characterization of delivery systems for nanomedicine Dr. John A. Dagata

source: NCI CNPlan Benefits and advantages of nanomedicine: Targeted nanoparticle delivery systems One of the most promising nanomedicine platforms Use an engineered virus-like particle to direct therapeutics & diagnostics only to cancer cells Lower dosage Reduced costs & side effects

NIST-NCI-FDA Alliance: Impact of healthcare costs on the US economy Protocols and standards for faster move into clinical trials CNPlan (NCI 2004) Critical Path Initiative (FDA 2004) Technology: Methodologies for nonspecific adhesion of bio-nanoparticles to surfaces for high-magnification imaging and characterization

Commercial Applications: Drug discovery and development Quality assurance (manufacturability and potency) Environmental health & safety

Drug discovery and development (collaboration with Esther Chang, Georgetown University Medical Center)

500 nm Metrology of soft material: Small sample volume (10  L) Adjustment of solution properties (essential for actual drug formulations) Fluid scanning probe microscopy of intact liposomes Non-optical statistical size distribution and zeta potential SPM tip SPIO NDS tip probing liposome tip probing SPIO

Collaboration Opportunities: CRADA SBIR For technical details see the posters: Physical characterization of liposome-based targeted nanoparticle delivery systems with encapsulated MRI contrast agents Imaging, characterization, and manipulation of nanobioparticles: Fluid scanning probe and surface zeta potential measurements of targeted delivery systems N. Farkas, et al.

Contact Information: John A. Dagata Precision Engineering Division Manufacturing Engineering Laboratory National Institute of Standards & Technology 100 Bureau Drive MS 8212 Gaithersburg MD tel fax